Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Impact Map
Manufacturing Partnerships
Our Science
Pipeline
Publications
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
All Publications
Filter:
Program
Medical Countermeasures
Opioid Antagonist
Filter
April 26, 2022
Exposure-Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product
Read More
January 21, 2022
Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) (BAT(®)) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review
Read More
January 16, 2022
Letter to the Editor on Ghitani SA et al. Outbreak of Foodborne Botulism in Alexandria, Egypt. Modulating Indications for Administration of Heptavalent Botulinum Antitoxin
Read More
August 30, 2021
Enhanced Safety Surveillance Study of ACAM2000 Smallpox Vaccine Among US Military Service Members
Read More
July 21, 2021
Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular Administrations
Read More
November 18, 2020
Efficacy of the AV7909 Anthrax Vaccine Candidate in Guinea Pigs and Nonhuman Primates Following Two Immunizations Two Weeks Apart
Read More
October 18, 2020
Developmental and Reproductive Safety Evaluation of AV7909 Anthrax Vaccine Candidate in Rats
Read More
September 25, 2020
Prospective Safety Surveillance Study of ACAM2000 Smallpox Vaccine in Deploying Military Personnel
Read More
July 22, 2020
Repeat Dose Toxicity Study of the AV7909 Anthrax Vaccine Candidate in Juvenile Rats
Read More
May 16, 2020
Current Status and Trends in Prophylaxis and Management of Anthrax Disease
Read More
April 3, 2020
Organic and Inorganic Nanoparticle Vaccines for Prevention of Infectious Diseases
Read More
February 8, 2020
Development of a Guinea Pig Inhalational Anthrax Model for Evaluation of Post-Exposure Prophylaxis Efficacy of Anthrax Vaccines
Read More
1
2
3
4
